Maxim Group Keeps Their Hold Rating on Omeros (OMER)
November 16 2022 - 03:25PM
TipRanks
Maxim Group analyst Jason McCarthy maintained a Hold rating on
Omeros (OMER - Research Report) yesterday. The company's shares
opened today at $2.65.According to TipRanks, McCarthy is an analyst
with an average return of -38.2% and a 16.67% success rate.
McCarthy covers the Healthcare sector, focusing on stocks such as
Immutep, Daré Bioscience, and Adial Pharmaceuticals.In addition to
Maxim Group, Omeros also received a Hold from Needham's Serge
Belanger in a report issued on November 10. However, on the same
day, Cantor Fitzgerald maintained a Buy rating on Omeros (NASDAQ:
OMER).See today’s best-performing stocks on TipRanks >>The
company has a one-year high of $8.45 and a one-year low of
$1.86.
https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-omeros-omer-2?utm_source=advfn.com&utm_medium=referral
Omeros (NASDAQ:OMER)
Historical Stock Chart
From May 2023 to Jun 2023
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Jun 2022 to Jun 2023